GUMM - Eliminate the Common Cold Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mike M who wrote (4129)	4/24/2002 3:03:20 PM
From: Hank	Read Replies (1) of 5582

"Mr. Johnson continued, "We are committed to maintaining growth of the Zicam brand, while working to provide shareholders with increased value. However expectations of the market and our shareholders, particularly as they relate to earnings, should be tempered by our strong commitment to our new and emerging corporate growth strategy for 2002 and beyond. Also, our products are highly seasonal and our results are greatly impacted by our commitment to promote our products and strengthen the Zicam franchise. " Maybe you should take Mr. Johnson's advice and "temper" your expectations Mikey. Comparing the likes of GUMM to PFE is pretty funny. I bet PFE goes up and STAYS up before GUMM does.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next